Mologic Inc.
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- globalaccessdx.com
- Founded
- 2003
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | $4,475,450 |
Contract awards
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Georgia TECH Applied Research Corp | N6600122C4012 | $2,321,164 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| P B M | South Brunswick Township, NJ | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Pathogendx Inc. | Tucson, AZ | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Visby Medical, Inc. | San Jose, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Sekisui Diagnostics, LLC | San Diego, CA | 325413 In-Vitro Diagnostic Substance Manufacturing |
| DCN Diagnostics | Carlsbad, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Mologic Inc. is a leading developer and manufacturer of advanced lateral flow immunoassay tests for human healthcare, animal health, environmental and food safety markets. Through prime federal contracts, Mologic Inc. has provided SARS-CoV-2 antigen home tests to the National Institutes of Health to accelerate COVID-19 diagnostics. This $16.2 million firm fixed price contract aims to deliver tests through May 2024 out of Mologic's New Hampshire facility. Mologic Inc. has also provided custom antibody development to the NIH's National Institute of Allergy and Infectious Diseases through a $59,010 purchase order completed in June 2020.
As a subcontractor, Mologic Inc. has undertaken unspecified efforts for the Department of Defense through prime contractor Georgia Tech Applied Research Corporation.
Through a federal grant subaward from the University of Massachusetts Medical School, Mologic Inc. is conducting clinical studies on multiple new point-of-care COVID-19 testing devices to examine sensitivity, specificity, usability, feasibility and safety. This work supports the NIH's goal of facilitating public health through rapid testing technologies.
Quick answers
Is Mologic Inc. registered in SAM.gov?
Mologic Inc.'s SAM.gov registration expired on July 15, 2025.
What is Mologic Inc.'s CAGE code?
Mologic Inc.'s CAGE code is 894Z0, and its Unique Entity ID (UEI) is UJXLCMKNFXD4.
How much has Mologic Inc. received in federal contracts?
Federal contracts obligated $4,475,450 to Mologic Inc. in fiscal years 2023 through 2027.
What is Mologic Inc.'s most recent federal award?
Mologic Inc.'s most recent federal contract award is Rapid acceleration of diagnostics (RADX) program tech project #7697: sars-COV-2 AG home test (75N92021C00010), from National Heart Lung and Blood Institute (NIH), on March 31, 2021.
On GovTribe
See Mologic Inc.'s full federal record
- Federal contract awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors